Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Nationwide Multicentric Retrospective and Prospective Epidemiologic Survey of Bisphosphonate-related Osteonecrosis of the Jaws

View through CrossRef
Introduction: Bisphosphonate-related osteonecrosis of the jaws is considered to be a rare but severe complication of bisphosphonate therapy. The presumably multifactorial pathomechanisms of medication-related osteonecrosis of the jaws have not been fully elucidated so far. To understand this condition better data collection is essential. Although the number of scientific papers about this subject is large, only a few multicenter reports have been published. Management of this serious side effect is a real challenge and requires a multidisciplinary approach. Material and methods: We present a novel cloud-based data collection system for the evaluation of the risk factors of bisphosphonate-related osteonecrosis of the jaws. Web-based questionnaire and database have been set up and made available to voluntary researchers and clinicians in oral and maxillofacial surgery in Hungary and Slovakia. Results: To date, fifteen colleagues from eight maxillofacial units have joined the study. Data of 180 patients have been recorded. Collected data were statistically analysed and evaluated from an epidemiological point of view. Discussions: Authors consider cloud-based multicenter data collection a useful tool that allows for real-time collaboration between users, facilitates fast data entry and analysis, and thus considerably contributes to widening our knowledge of bisphosphonate-related osteonecrosis of the jaws. Conclusions: Although several issues are still open regarding the management of the disorder, this study may help to develop evidence-based, individualized, stage-adapted therapeutic strategies that will replace the previous empirical treatment.
University of Szeged
Title: Nationwide Multicentric Retrospective and Prospective Epidemiologic Survey of Bisphosphonate-related Osteonecrosis of the Jaws
Description:
Introduction: Bisphosphonate-related osteonecrosis of the jaws is considered to be a rare but severe complication of bisphosphonate therapy.
The presumably multifactorial pathomechanisms of medication-related osteonecrosis of the jaws have not been fully elucidated so far.
To understand this condition better data collection is essential.
Although the number of scientific papers about this subject is large, only a few multicenter reports have been published.
Management of this serious side effect is a real challenge and requires a multidisciplinary approach.
Material and methods: We present a novel cloud-based data collection system for the evaluation of the risk factors of bisphosphonate-related osteonecrosis of the jaws.
Web-based questionnaire and database have been set up and made available to voluntary researchers and clinicians in oral and maxillofacial surgery in Hungary and Slovakia.
Results: To date, fifteen colleagues from eight maxillofacial units have joined the study.
Data of 180 patients have been recorded.
Collected data were statistically analysed and evaluated from an epidemiological point of view.
Discussions: Authors consider cloud-based multicenter data collection a useful tool that allows for real-time collaboration between users, facilitates fast data entry and analysis, and thus considerably contributes to widening our knowledge of bisphosphonate-related osteonecrosis of the jaws.
Conclusions: Although several issues are still open regarding the management of the disorder, this study may help to develop evidence-based, individualized, stage-adapted therapeutic strategies that will replace the previous empirical treatment.

Related Results

Asymptomatic Osteonecrosis of the Trochlea in an Adolescent: A Case Report
Asymptomatic Osteonecrosis of the Trochlea in an Adolescent: A Case Report
Abstract Introduction Osteonecrosis, also known as avascular necrosis, aseptic necrosis, or ischemic necrosis, results from a temporary or permanent halt in blood flow to a portion...
Hypofibrinolysis: A common, major cause of osteonecrosis
Hypofibrinolysis: A common, major cause of osteonecrosis
AbstractIn 30 patients with osteonecrosis of the hip (12 idiopathic, 18 secondary), we assessed the role of hypofibrinolysis mediated by high levels of piasminogen activator inhibi...
Osteonecrosis of the Jaw Associated with Pamidronate Therapy.
Osteonecrosis of the Jaw Associated with Pamidronate Therapy.
Abstract BACKGROUND: Bisphosphonates, as a class of medication, fulfill an essential role serving to modify the natural history of bone disease associated with multi...
Clinical case of preiser disease, bilateral femoral head and humeral head osteonecrosis associated with chronic corticosteroid therapy
Clinical case of preiser disease, bilateral femoral head and humeral head osteonecrosis associated with chronic corticosteroid therapy
Osteonecrosis is a pathologic process that is associated with numerous conditions and therapeutic interventions. Most commonly the hip is involved but almost any bone can develop o...
Bisphosphonate–induced osteonecrose of the jaws in patients with osteoporosis
Bisphosphonate–induced osteonecrose of the jaws in patients with osteoporosis
Bisphosphonate–induced maxillary osteonecrosis represents a pathology of the oral cavity characterized by the presence of ulcerations, exposure of necrotic bone tissue and secondar...
Importance of correct management of bisphosphonate-related osteonecrosis of the jaw
Importance of correct management of bisphosphonate-related osteonecrosis of the jaw
Introduction: Osteonecrosis results from local and systemic factors that compromise blood flow in bone tissues, being relatively frequent in maxillary bones. In recent years, there...
Osteonecrosis of the jaw associated with pamidronate therapy
Osteonecrosis of the jaw associated with pamidronate therapy
AbstractBisphosphonates are commonly used in the treatment and prevention of osteoporosis, and they are also an important therapeutic adjunct in multiple myeloma and other cancers ...

Back to Top